Breast cancer trends: a marriage between clinical trial evidence and epidemiology.
Berry
Donald A
DA
Ravdin
Peter M
PM
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology*; D015984:Causality; D002986:Clinical Trials as Topic; D016208:Databases, Factual; D018450:Disease Progression; D042241:Early Diagnosis; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D008327:Mammography / Q000706:statistics & numerical data; D008403:Mass Screening / Q000706:statistics & numerical data; D008593:Menopause; D008875:Middle Aged; D009017:Morbidity / Q000639:trends; D009376:Neoplasms, Hormone-Dependent / Q000000981:diagnostic imaging / Q000453:epidemiology; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012307:Risk Factors; D018426:SEER Program; D014481:United States / Q000453:epidemiology
D004967:Estrogens; D011372:Progestins